Emergent Biosolutions Inc.
Could not find a ticker for this position, may be a filing error
A specialty biopharmaceutical company that makes medicines to protect against biological threats and opioid overdoses. Its best-known products include BioThrax, a vaccine against anthrax, and NARCAN, a nasal spray that reverses opioid overdoses and became the first naloxone product sold over the counter without a prescription. Founded in 1998 as BioPort, the company took over Michigan's anthrax vaccine facilities and later renamed itself Emergent BioSolutions, a nod to its role in helping people emerge from public health emergencies.
2.875% Convertible Senior Notes due 2021
2.02 Results of Operations and Financial Condition · 2.05 Costs Associated with Exit or Disposal Activities · 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 1.02 Termination of a Material Definitive Agreement · 3.02 Unregistered Sales of Equity Securities · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits